For the nine genes in the risk model, boxplot showed that FABP6, ITK, PDGFRA, NFATC and CTSE were strongly correlated with the clinical stage of the BLCA patients (Fig. 11A). This evidence concerns the gene PDGFRA and bladder transitional cell carcinoma.